Mustang Bio Announces FDA Acceptance of IND Application for MB-109, a Novel Combination of MB-101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus), for the Treatment of Recurrent Glioblastoma and High-Grade Astrocytoma
26 oct. 2023 09h00 HE
|
Mustang Bio, Inc.
MB‐101 (IL13Rα2‐targeted CAR-T cell therapy) and MB-108 (HSV-1 oncolytic virus) are separately well tolerated in patients with recurrent GBM in ongoing Phase 1 clinical trials; preclinical data...
Ivy Brain Tumor Center Announces Results of Phase 0/1 Study in Recurrent Glioblastoma Patients at the European Society for Medical Oncology (ESMO) 2023 Congress
18 oct. 2023 02h00 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute announced initial results from a Phase 0/1 clinical trial of the Ataxia telangiectasia...
Ivy Brain Tumor Center Opens Novel Clinical Trial to Test Direct-to-Tumor Drug Delivery Method
18 juil. 2023 09h30 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, July 18, 2023 (GLOBE NEWSWIRE) -- In an effort to discover new treatments for brain tumors, such as glioblastoma, the Ivy Brain Tumor Center at Barrow Neurological Institute, announced...
Results of Annual General Meeting and General Meeting
14 juin 2023 08h30 HE
|
Biodexa Pharmaceuticals PLC
Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Results of Annual General Meeting and General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a...
Ivy Brain Tumor Center Announces Interim Results of Two Clinical Trials Targeting High-Grade Glioma
02 juin 2023 15h50 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, June 02, 2023 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the nation’s largest early-phase drug development program dedicated to brain cancer, is...
Brain Cancer Canada Grants Research Funds to Improve Survival Rates for Glioblastoma and Other Gliomas
25 mai 2023 11h00 HE
|
Brain Cancer Canada
TORONTO, May 25, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada, a leading charity in the fight against brain cancer, is delighted to announce a $50,000 research grant to Dr. Amit Singnurkar at...
Brain Cancer Canada Awards CAD 50,000 Grant for Innovative Research to Improve Brain Cancer Diagnosis and Treatment
04 mai 2023 10h00 HE
|
Brain Cancer Canada
TORONTO, May 04, 2023 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $50,000 grant to support research on more effective diagnosis and treatment for adult brain cancer patients. ...
ITM, Helmholtz Munich and University Hospital Münster Announce Start of Phase I Clinical Trial with Radiotherapeutic ITM-31 for Glioblastoma
13 mars 2023 06h13 HE
|
ITM Isotope Technologies Munich SE
Garching/Munich, Munich and Münster, Germany, March 13, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, Helmholtz Munich and the Departments of...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
22 févr. 2023 09h08 HE
|
Glioblastoma Foundation
DURHAM, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Morgan Myles was a top three finalist on the latest season of NBC's The Voice, and now she is hopeful to use her voice in a different way — to share...
The Voice Finalist Morgan Myles Joins the Glioblastoma Foundation® as a Celebrity Ambassador to Raise Awareness and Funding for Glioblastoma
22 févr. 2023 09h08 HE
|
Glioblastoma Foundation
DURHAM, N.C., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Morgan Myles was a top three finalist on the latest season of NBC's The Voice, and now she is hopeful to use her voice in a different way — to share...